Morris MJ - Search Results

1

Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.

Schmidt AL, Tucker MD, Bakouny Z, Labaki C, Hsu CY, Shyr Y, Armstrong AJ, Beer TM, Bijjula RR, Bilen MA, Connell CF, Dawsey SJ, Faller B, Gao X, Gartrell BA, Gill D, Gulati S, Halabi S, Hwang C, Joshi M, Khaki AR, Menon H, Morris MJ, Puc M, Russell KB, Shah NJ, Sharifi N, Shaya J, Schweizer MT, Steinharter J, Wulff-Burchfield EM, Xu W, Zhu J, Mishra S, Grivas P, Rini BI, Warner JL, Zhang T, Choueiri TK, Gupta S, McKay RR. Schmidt AL, et al. Among authors: morris mj. JAMA Netw Open. 2021 Nov 1;4(11):e2134330. doi: 10.1001/jamanetworkopen.2021.34330. JAMA Netw Open. 2021. PMID: 34767021 Free PMC article.

2

Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.

Kantoff PW, Beer TM, D'Amico AV, Dipaola RS, Eisenberger MA, Hussain MH, Kelly WK, Mathew P, Morris MJ, Ryan CJ, Sandler HM, Thompson IM, Carroll PR. Kantoff PW, et al. Among authors: morris mj. J Urol. 2007 Sep;178(3 Pt 2):S5-8; quiz S4. doi: 10.1016/j.juro.2007.03.137. Epub 2007 Jul 20. J Urol. 2007. PMID: 17644118 No abstract available.

3

Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions.

Gignac GA, Morris MJ, Hussain M. Gignac GA, et al. Among authors: morris mj. J Urol. 2007 Sep;178(3 Pt 2):S30-5. doi: 10.1016/j.juro.2007.04.033. Epub 2007 Jul 20. J Urol. 2007. PMID: 17644121

4

A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer.

Morris MJ, Kelly WK, Slovin S, Ryan C, Eicher C, Heller G, Scher HI. Morris MJ, et al. J Urol. 2007 Dec;178(6):2378-83; discussion 2383-4. doi: 10.1016/j.juro.2007.08.015. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936848 Clinical Trial.

5

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

Morris MJ, Basch EM, Wilding G, Hussain M, Carducci MA, Higano C, Kantoff P, Oh WK, Small EJ, George D, Mathew P, Beer TM, Slovin SF, Ryan C, Logothetis C, Scher HI. Morris MJ, et al. Clin Genitourin Cancer. 2009 Jan;7(1):51-7. doi: 10.3816/CGC.2009.n.009. Clin Genitourin Cancer. 2009. PMID: 19213669 Free PMC article.

6

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

Scher HI, Beer TM, Higano CS, Anand A, Taplin ME, Efstathiou E, Rathkopf D, Shelkey J, Yu EY, Alumkal J, Hung D, Hirmand M, Seely L, Morris MJ, Danila DC, Humm J, Larson S, Fleisher M, Sawyers CL; Prostate Cancer Foundation/Department of Defense Prostate Cancer Clinical Trials Consortium. Scher HI, et al. Among authors: morris mj. Lancet. 2010 Apr 24;375(9724):1437-46. doi: 10.1016/S0140-6736(10)60172-9. Epub 2010 Apr 14. Lancet. 2010. PMID: 20398925 Free PMC article. Clinical Trial.

7

Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer.

Ito K, Elkin EB, Girotra M, Morris MJ. Ito K, et al. Among authors: morris mj. Ann Intern Med. 2010 May 18;152(10):621-9. doi: 10.7326/0003-4819-152-10-201005180-00002. Ann Intern Med. 2010. PMID: 20479027 Free PMC article.

8

Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.

Gallagher DJ, Cronin AM, Milowsky MI, Morris MJ, Bhatia J, Scardino PT, Eastham JA, Offit K, Robson ME. Gallagher DJ, et al. Among authors: morris mj. BJU Int. 2012 Mar;109(5):713-9. doi: 10.1111/j.1464-410X.2011.10292.x. Epub 2011 Jul 14. BJU Int. 2012. PMID: 21756279 Free PMC article.

9

Androgen deprivation and thromboembolic events in men with prostate cancer.

Ehdaie B, Atoria CL, Gupta A, Feifer A, Lowrance WT, Morris MJ, Scardino PT, Eastham JA, Elkin EB. Ehdaie B, et al. Among authors: morris mj. Cancer. 2012 Jul 1;118(13):3397-406. doi: 10.1002/cncr.26623. Epub 2011 Nov 9. Cancer. 2012. PMID: 22072494 Free PMC article.

10

Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis.

Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ. Hatzoglou V, et al. Among authors: morris mj. J Neuroimaging. 2014 Mar-Apr;24(2):161-6. doi: 10.1111/j.1552-6569.2012.00767.x. Epub 2012 Dec 28. J Neuroimaging. 2014. PMID: 23279641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

836 results

Search Page